361 related articles for article (PubMed ID: 26098499)
1. Approach to drug-resistant cytomegalovirus in transplant recipients.
Chou S
Curr Opin Infect Dis; 2015 Aug; 28(4):293-9. PubMed ID: 26098499
[TBL] [Abstract][Full Text] [Related]
2. Drug-resistant cytomegalovirus: clinical implications of specific mutations.
Razonable RR
Curr Opin Organ Transplant; 2018 Aug; 23(4):388-394. PubMed ID: 29794552
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
[TBL] [Abstract][Full Text] [Related]
4. New Locus of Drug Resistance in the Human Cytomegalovirus UL56 Gene Revealed by
Chou S; Satterwhite LE; Ercolani RJ
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914965
[TBL] [Abstract][Full Text] [Related]
5. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD
Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
[TBL] [Abstract][Full Text] [Related]
6. Genotypic resistance of cytomegalovirus to antivirals in hematopoietic stem cell transplant recipients from Portugal: A retrospective study.
Campos AB; Ribeiro J; Pinho Vaz C; Campilho F; Branca R; Campos A; Baldaque I; Medeiros R; Boutolleau D; Sousa H
Antiviral Res; 2017 Feb; 138():86-92. PubMed ID: 27887982
[TBL] [Abstract][Full Text] [Related]
7. The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.
Choi SH; Hwang JY; Park KS; Kim Y; Lee SH; Yoo KH; Kang ES; Ahn JH; Sung KW; Koo HH; Kim YJ
Transpl Infect Dis; 2014 Dec; 16(6):919-29. PubMed ID: 25405808
[TBL] [Abstract][Full Text] [Related]
8. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.
Hantz S; Garnier-Geoffroy F; Mazeron MC; Garrigue I; Merville P; Mengelle C; Rostaing L; Saint Marcoux F; Essig M; Rerolle JP; Cotin S; Germi R; Pillet S; Lebranchu Y; Turlure P; Alain S;
J Antimicrob Chemother; 2010 Dec; 65(12):2628-40. PubMed ID: 20961907
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
10. Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance.
Chou S
Antiviral Res; 2020 Apr; 176():104711. PubMed ID: 31940472
[TBL] [Abstract][Full Text] [Related]
11. Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient.
Jung S; Michel M; Stamminger T; Michel D
BMC Infect Dis; 2019 May; 19(1):388. PubMed ID: 31068147
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Mutations in the Gene Encoding Cytomegalovirus DNA Polymerase in a Phase 2 Clinical Trial of Brincidofovir Prophylaxis.
Lanier ER; Foster S; Brundage T; Chou S; Prichard MN; Kleiboeker S; Wilson C; Colville D; Mommeja-Marin H
J Infect Dis; 2016 Jul; 214(1):32-5. PubMed ID: 26941282
[TBL] [Abstract][Full Text] [Related]
13. Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art.
Campos AB; Ribeiro J; Boutolleau D; Sousa H
Rev Med Virol; 2016 May; 26(3):161-82. PubMed ID: 26990717
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing.
Guermouche H; Burrel S; Mercier-Darty M; Kofman T; Rogier O; Pawlotsky JM; Boutolleau D; Rodriguez C
Antiviral Res; 2020 Jan; 173():104647. PubMed ID: 31706899
[TBL] [Abstract][Full Text] [Related]
15. Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients.
Lurain NS; Bhorade SM; Pursell KJ; Avery RK; Yeldandi VV; Isada CM; Robert ES; Kohn DJ; Arens MQ; Garrity ER; Taege AJ; Mullen MG; Todd KM; Bremer JW; Yen-Lieberman B
J Infect Dis; 2002 Sep; 186(6):760-8. PubMed ID: 12198609
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of coexisting HCMV-UL97 and UL54 drug-resistance associated mutations in patients after haematopoietic cell transplantation.
Göhring K; Wolf D; Bethge W; Mikeler E; Faul C; Vogel W; Vöhringer MC; Jahn G; Hamprecht K
J Clin Virol; 2013 May; 57(1):43-9. PubMed ID: 23375740
[TBL] [Abstract][Full Text] [Related]
17. Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management.
Khawaja F; Batista MV; El Haddad L; Chemaly RF
Curr Opin Infect Dis; 2019 Dec; 32(6):565-574. PubMed ID: 31567572
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus drug resistance mutations in transplant recipients with suspected resistance.
Recio V; González I; Tarragó D
Virol J; 2023 Jul; 20(1):153. PubMed ID: 37464399
[TBL] [Abstract][Full Text] [Related]
19. Assessment of UL56 Mutations before Letermovir Therapy in Refractory Cytomegalovirus Transplant Recipients.
Santos Bravo M; Tilloy V; Plault N; Palomino SS; Mosquera MM; Navarro Gabriel M; Fernández Avilés F; Suárez Lledó M; Rovira M; Moreno A; Linares L; Bodro M; Hantz S; Alain S; Marcos MÁ
Microbiol Spectr; 2022 Apr; 10(2):e0019122. PubMed ID: 35343771
[No Abstract] [Full Text] [Related]
20. Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing.
Chou S; Ercolani RJ; Sahoo MK; Lefterova MI; Strasfeld LM; Pinsky BA
Antimicrob Agents Chemother; 2014 Aug; 58(8):4697-702. PubMed ID: 24890586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
